Sunday, October 12, 2008

Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.

To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .


----------------------------------------------
** BREAST CANCER News **

1,848 Breast Cancer Diagnoses And 398 Deaths In Kansas During 2002-2006
http://www.medicalnewstoday.com/articles/125142.php
Breast cancer is the most common type of cancer diagnosed in women but screening and early detection can help identify cancer in its early stages when the disease is most treatable. October is Breast Cancer Awareness Month and women should become informed about their risks of developing cancer and how effective screening for the disease is.

Governor Blagojevich And Walgreens Team Up To Encourage Women To Get Screened During Breast Cancer Awareness Month, Illinois
http://www.medicalnewstoday.com/articles/125139.php
Celebrating the one year anniversary of Governor Rod R. Blagojevich's groundbreaking expansion of the Illinois Breast and Cervical Cancer Program (IBCCP), Illinois Department of Public Health Director Dr.

----------------------------------------------
** CANCER / ONCOLOGY News **

Cyclacel Announces Completion Of Enrollment In Phase 2 Trial Of Sapacitabine In Elderly AML
http://www.medicalnewstoday.com/articles/125130.php
lCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced today the completion of enrollment as per protocol in the Phase 2 clinical trial of sapacitabine, the Company's oral nucleoside analogue, in elderly patients with acute myeloid leukemia (AML).

ImmunoCellular Therapeutics Announces Filing Of Patent Application For A Novel Cancer Stem Cell Vaccine Technology
http://www.medicalnewstoday.com/articles/125124.php
ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells.

----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **

No news for this category today.

----------------------------------------------
** COLORECTAL CANCER News **

No news for this category today.

----------------------------------------------
** LUNG CANCER News **

No news for this category today.

----------------------------------------------
** LYMPHOMA / LEUKEMIA News **

On The Trail Of A Targeted Therapy For Blood Cancers: Exploring Protein Critical To Blood Cell Development
http://www.medicalnewstoday.com/articles/125144.php
Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic effects of chemotherapy in children and adults.

Cyclacel Announces Completion Of Enrollment In Phase 2 Trial Of Sapacitabine In Elderly AML
http://www.medicalnewstoday.com/articles/125130.php
lCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced today the completion of enrollment as per protocol in the Phase 2 clinical trial of sapacitabine, the Company's oral nucleoside analogue, in elderly patients with acute myeloid leukemia (AML).

----------------------------------------------
** PROSTATE / PROSTATE CANCER News **

No news for this category today.

-------------------------------------------------------------

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

No comments: